Low Whole-Blood S-Adenosylmethionine and Correlation between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery Disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 6, 1996, Pages 727-733

  Loehrer, Franziska M T ^a   Angst, Christian P ^a   Haefeli, Walter E ^c   Jordan, Paul P ^b   Ritz, Rudolf ^c   Fowler, Brian ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Kantonsspital Basel   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

5 adenosylmethionine; 5 methyltetrahydrofolate; Coronary artery disease; Homocysteine; Methylenetetrahydrofolate reductase

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE; S ADENOSYLMETHIONINE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METABOLISM; PRIORITY JOURNAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; ISOENZYMES; LYMPHOCYTES; MALE; METHIONINE ADENOSYLTRANSFERASE; METHYLATION; MIDDLE AGED; RISK FACTORS; S-ADENOSYLMETHIONINE; TETRAHYDROFOLATES;

EID: 0029896088     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.6.727     Document Type: Article

References (46)

1. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274:1049-1057.
2. Rang SS, Wong PW, Cook HY. Protein-bound homocyst(e)ine: a possible risk factor for coronary artery disease. J Clin Invest. 1986; 77:1482-1486.
3. Genest JJ Jr, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol. 1990;16:1114-1119.
4. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma hornocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877-881.
5. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332: 286-291.
6. Hopkins PN, Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR. Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1995;15:1314-1320.
7. Boers GHJ, Smals AGH, Trijbeis FJM, Fowler B, Bakkeren JA, Schoonderwaldt HC, Kleijer WJ, Kloppenborg PWC Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709-715.
8. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocys-t(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 1989;79:1180-1188.
9. Taylor LM Jr, DeFrang RD, Harris EJ Jr, Porter JM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg. 1991;13:128-136.
10. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke. 1990;21:572-576.
11. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 1989;79: 139-146.
12. Brattström L, Hardebo JE, Hultberg BL. Moderate homocysteinemia: a possible risk factor for the arteriosclerotic cerebro-vascular disease. Stroke. 1984;15;1012-1016.
13. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
14. Genest JJ Jr, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ, Malinow MR. Prevalence of familial hyperhomocys-t(e)inemia in men with premature coronary artery disease. Arterioscler Thromb. 1991;11:1129-1136.
15. Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb. 1993;13:1253-1260.
16. Kozich V, Kraus E, De Franchis R, Fowler B, Boers GHJ, Graham I, Kraus JP, Hyperhomocysteinemia in premature arterial disease: examination of cystathionine β-synthase alleles at the molecular level. Hum Mol Genet. 1995;4:623-629.
17. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet. 1991;48: 536-545.
18. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet. 1995; 56:142-150.
19. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
20. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyper-homocysteinemia. Am J Clin Nutr. 1993;57:47-53.
21. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, ed. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. New York, NY: Marcel Dekker, Inc; 1992:183-236.
22. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO, Macaluso M, Acton RT, Copeland RB, Cousins AL. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr. 1994;59:940-948.
23. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb. 1994;14:465-470.
24. Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Brattström L. Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. J Intern Med. 1995;237: 381-388.
25. Jencks DA, Matthews RG. Allosteric inhibition of methylenetetra-hydrofolate reductase by adenosylmethionine. J Biol Chem. 1987; 262:2485-2493.
26. Finkelstein JD, Kyle WE, Martin JJ, Pick AM. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochem Biophys Res Commun. 1975;66:81-87.
27. Selhub J, Miller JW. The pathogenesis of homocysteinemia: inter-ruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr. 1992;55:131-138.
28. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J. Folatedeficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine's co-ordinate regulation of homocysteine metabolism. Biochem J. 1994;298:415-419.
29. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homo cysteine in plasma and serum. Eur J Clin Chem Clin Biochem. 1991;29:549-554.
30. Leeming RJ, Pollock A, Melville LJ, Hamon CGB. Measurement of 5-methyltetrahydrofolic acid in man by high-performance liquid chromatography. Metabolism. 1990;39:902-904.
31. Bottiglieri T. High performance liquid Chromatographic analysis of S-adenosylmethionine and S-adenosylhomocysteine in animal tissues: the effect of exposure to nitrous oxide. Biomed Chromatogr. 1990;4:239-241.
32. Suormala T, Wick H, Bonjour JP, Baumgartner ER. Rapid differential diagnosis of carboxylase deficiencies and evaluation for biotin-responsiveness in a single blood sample. Clin Chim Acta. 1985;145:151-162.
33. Rosenblatt DS, Erbe RW. Methylenetetrahydrofolate reductase in cultured human cells, I: growth and metabolic studies. Pediatr Res. 1977;11:1137-1141.
34. SAS/STAT User's Guide, Version 6, Vol 2. Cary, NC: SAS/STAT Institute Inc; 1990.
35. Chauveau P, Chadefaux B, Coude M, Aupetit J, Hannedouche T, Kamoun P, Jungers P. Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrolyte Metab. 1992;18:196-198.
36. Geigy Scientific Tables, Vol 3. 8th ed. Basel, Switzerland: Ciba-Geigy Ltd; 1980.
37. Dettli L. The kidney in pre-clinical and clinical pharmacokinetics. Jpn J Clin Pharmacol Ther. 1984;15:241-234.
38. Andersson A, Brattström L, Israelsson B, Isaksson A, Hamfelt A, Hultberg B. Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. Eur J Clin Invest. 1992;22:79-87.
39. Brattström L, Israelsson B, Norrving B, Bergqvist D, Thörne J, Hultberg B, Hamfelt A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: effects of pyridoxine and folic acid treatment. Atherosclerosis. 1990; 81:51-60.
40. Dalery K, Lussiers-Cacan S, Selhub J, Davignon J, Latour Y, Genest JJ Jr. Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. Am J Cardiol. 1995;75:1107-1111.
41. Friedrich W. Folic acid and unconjugated pteridins. In: Vitamins. New York, NY: Walter de Gruyter, Inc; 1988:623-752.
42. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, Trijbels FJM, Eskes TKAB, van den Heuvel LP, Mariman ECM, den Heyer M, Rozen R, Blom HJ. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1070-1071.
43. Blom HJ, Davidson AJ, Finkelstein JD, Luder AS, Bernardini I, Martin JJ, Tangerman A, Trijbels JMF, Mudd SH, Goodman SI, Gahl WA. Persistent hypermethioninaemia with dominant inheritance. J Inherit Metab Dis. 1992;15:188-197.
44. Varela-Moreiras G, Ragel C, Ruiz-Roso B. Effects of prolonged aspirin or acetaminophen administration to rats on liver folate content and distribution: relation to DNA methylation and S-adenosylmethionine, Int J Vitam Nutr Res. 1994;64:41-46.
45. Finkelstein JD. Methionine metabolism in mammals. J. Nutr Biochem. 1990;1:228-237.
46. Hoffmann DR, Marion DW, Cornatzer WE, Duerre JA. S-adenosyl-methionine and S-adenosylhomocysteine metabolism in isolated rat liver: effects of L-methionine, L-homocysteine and adenosine. J Biol Chem. 1980;255:10822-10827.